{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:26:27Z","timestamp":1792689987811,"version":"4.5.0"},"reference-count":102,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T00:00:00Z","timestamp":1555027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00794","type":"journal-article","created":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T00:39:19Z","timestamp":1555029559000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":129,"title":["The Long Pentraxin PTX3 as a Humoral Innate Immunity Functional Player and Biomarker of Infections and Sepsis"],"prefix":"10.3389","volume":"10","author":[{"given":"R\u00e9mi","family":"Porte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadaf","family":"Davoudian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Asgari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Parente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Garlanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Bottazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,4,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1152\/physrev.00016.2017","article-title":"Ptx3, a humoral pattern recognition molecule, in innate immunity, tissue repair, and cancer","volume":"98","author":"Garlanda","year":"2018","journal-title":"Physiol Rev"},{"key":"B2","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev-immunol-030409-101305","article-title":"An integrated view of humoral innate immunity: pentraxins as a paradigm","volume":"28","author":"Bottazzi","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"10147","DOI":"10.1074\/jbc.M708535200","article-title":"Structural characterization of PTX3 disulfide bond network and its multimeric status in cumulus matrix organization","volume":"283","author":"Inforzato","year":"2008","journal-title":"J Biol Chem"},{"key":"B4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1146\/annurev.immunol.23.021704.115756","article-title":"Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility","volume":"23","author":"Garlanda","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1084\/jem.20061301","article-title":"The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps","volume":"204","author":"Jaillon","year":"2007","journal-title":"J Exp Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.cellimm.2007.09.003","article-title":"Lipopolysaccharide induced expression of pentraxin 3 in human neutrophils and monocyte-derived macrophages","volume":"248","author":"Imamura","year":"2007","journal-title":"Cell Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1084\/jem.20150282","article-title":"The soluble pattern recognition receptor PTX3 links humoral innate and adaptive immune responses by helping marginal zone B cells","volume":"213","author":"Chorny","year":"2016","journal-title":"J Exp Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/ni.1854","article-title":"Regulation of leukocyte recruitment by the long pentraxin PTX3","volume":"11","author":"Deban","year":"2010","journal-title":"Nat Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nature01195","article-title":"Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response","volume":"420","author":"Garlanda","year":"2002","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1182\/blood-2006-03-009266","article-title":"Pentraxin 3 protects from MCMV infection and reactivation through TLR sensing pathways leading to IRF3 activation","volume":"108","author":"Bozza","year":"2006","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.4049\/jimmunol.180.5.3391","article-title":"Antiviral activity of the long chain pentraxin PTX3 against influenza viruses","volume":"180","author":"Reading","year":"2008","journal-title":"J Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.immuni.2014.02.015","article-title":"The humoral pattern recognition molecule PTX3 is a key component of innate immunity against urinary tract infection","volume":"40","author":"Jaillon","year":"2014","journal-title":"Immunity"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e1007469","DOI":"10.1371\/journal.ppat.1007469","article-title":"Role of a fluid-phase PRR in fighting an intracellular pathogen: PTX3 in Shigella infection","volume":"14","author":"Ciancarella","year":"2018","journal-title":"PLoS Pathog"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e1004649","DOI":"10.1371\/journal.ppat.1004649","article-title":"Role of pentraxin 3 in shaping arthritogenic alphaviral disease: from enhanced viral replication to immunomodulation","volume":"11","author":"Foo","year":"2015","journal-title":"PLoS Pathog"},{"key":"B15","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1189\/jlb.0803371","article-title":"PTX3 function as an opsonin for the dectin-1-dependent internalization of zymosan by macrophages","volume":"75","author":"Diniz","year":"2004","journal-title":"J Leukoc Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.micinf.2005.12.017","article-title":"Dual function of the long pentraxin PTX3 in resistance against pulmonary infection with Klebsiella pneumoniae in transgenic mice","volume":"8","author":"Soares","year":"2006","journal-title":"Microbes Infect"},{"key":"B17","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1128\/AAC.48.11.4414-4421.2004","article-title":"Anti-Aspergillus fumigatus efficacy of pentraxin 3 alone and in combination with antifungals","volume":"48","author":"Gaziano","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"B18","doi-asserted-by":"publisher","first-page":"4513","DOI":"10.1128\/AAC.00674-10","article-title":"Efficacy of PTX3 in a rat model of invasive aspergillosis","volume":"54","author":"Lo Giudice","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"B19","doi-asserted-by":"publisher","first-page":"6400","DOI":"10.1128\/AAC.01000-12","article-title":"Effect of PTX3 and voriconazole combination in a rat model of invasive pulmonary aspergillosis","volume":"56","author":"Lo Giudice","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"B20","doi-asserted-by":"publisher","first-page":"6284","DOI":"10.1128\/AAC.03038-14","article-title":"Efficacy of PTX3 and posaconazole combination in a rat model of invasive pulmonary aspergillosis","volume":"58","author":"Marra","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"B21","doi-asserted-by":"publisher","first-page":"5425","DOI":"10.4049\/jimmunol.1002035","article-title":"The therapeutic potential of the humoral pattern recognition molecule PTX3 in chronic lung infection caused by Pseudomonas aeruginosa","volume":"186","author":"Moalli","year":"2011","journal-title":"J Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.4049\/jimmunol.1201642","article-title":"Prototypic long pentraxin PTX3 is present in breast milk, spreads in tissues, and protects neonate mice from Pseudomonas aeruginosa lung infection","volume":"191","author":"Jaillon","year":"2013","journal-title":"J Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/infdis\/jis636","article-title":"Response of CFTR-deficient mice to long-term chronic Pseudomonas aeruginosa infection and PTX3 therapy","volume":"208","author":"Paroni","year":"2013","journal-title":"J Infect Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.4049\/jimmunol.1301814","article-title":"A single amino acid substitution in the hemagglutinin of H3N2 subtype influenza A viruses is associated with resistance to the long pentraxin PTX3 and enhanced virulence in mice","volume":"192","author":"Job","year":"2014","journal-title":"J Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1189\/jlb.69.6.928","article-title":"TSG-14 transgenic mice have improved survival to endotoxemia and to CLP-induced sepsis","volume":"69","author":"Dias","year":"2001","journal-title":"J Leukoc Biol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"ra88","DOI":"10.1126\/scisignal.2005522","article-title":"Protective effect of the long pentraxin PTX3 against histone-mediated endothelial cell cytotoxicity in sepsis","volume":"7","author":"Daigo","year":"2014","journal-title":"Sci Signal"},{"key":"B27","doi-asserted-by":"publisher","first-page":"5170","DOI":"10.1182\/blood-2009-12-258376","article-title":"Role of complement and Fc{gamma} receptors in the protective activity of the long pentraxin PTX3 against Aspergillus fumigatus","volume":"116","author":"Moalli","year":"2010","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","first-page":"6299","DOI":"10.4049\/jimmunol.174.10.6299","article-title":"Binding of the complement inhibitor C4bp to serogroup B Neisseria meningitidis","volume":"174","author":"Jarva","year":"2005","journal-title":"J Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e0120807","DOI":"10.1371\/journal.pone.0120807","article-title":"Recognition of Neisseria meningitidis by the long pentraxin PTX3 and its role as an endogenous adjuvant","volume":"10","author":"Bottazzi","year":"2015","journal-title":"PLoS ONE"},{"key":"B30","doi-asserted-by":"publisher","first-page":"M111015073","DOI":"10.1074\/mcp.M111.015073","article-title":"The proteomic profile of circulating pentraxin 3 (PTX3) complex in sepsis demonstrates the interaction with azurocidin 1 and other components of neutrophil extracellular traps","volume":"11","author":"Daigo","year":"2012","journal-title":"Mol Cell Proteomics"},{"key":"B31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.yexmp.2014.11.009","article-title":"Differential expression of pentraxin 3 in neutrophils","volume":"98","author":"Razvina","year":"2015","journal-title":"Exp Mol Pathol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/immu.200310022","article-title":"Biochemical and functional characterization of the interaction between pentraxin 3 and C1q","volume":"33","author":"Nauta","year":"2003","journal-title":"Eur J Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1189\/jlb.0805445","article-title":"The tissue pentraxin PTX3 limits C1q-mediated complement activation and phagocytosis of apoptotic cells by dendritic cells","volume":"80","author":"Baruah","year":"2006","journal-title":"J Leukoc Biol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"28263","DOI":"10.1074\/jbc.M109.009225","article-title":"Synergy between ficolin-2 and pentraxin 3 boosts innate immune recognition and complement deposition","volume":"284","author":"Ma","year":"2009","journal-title":"J Biol Chem"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.4049\/jimmunol.1300382","article-title":"Ficolin-1-PTX3 complex formation promotes clearance of altered self-cells and modulates IL-8 production","volume":"191","author":"Ma","year":"2013","journal-title":"J Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1074\/jbc.M110.190637","article-title":"Heterocomplexes of mannose-binding lectin and the pentraxins PTX3 or serum amyloid P component trigger cross-activation of the complement system","volume":"286","author":"Ma","year":"2011","journal-title":"J Biol Chem"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.2353\/ajpath.2008.070593","article-title":"Multiple pathogenic roles of microvasculature in inflammatory bowel disease: a Jack of all trades","volume":"172","author":"Deban","year":"2008","journal-title":"Am J Pathol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"8433","DOI":"10.4049\/jimmunol.181.12.8433","article-title":"Binding of the long pentraxin PTX3 to Factor H: Interacting domains and function in the regulation of complement activation","volume":"181","author":"Deban","year":"2008","journal-title":"J Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e23991","DOI":"10.1371\/journal.pone.0023991","article-title":"Human pentraxin 3 binds to the complement regulator c4b-binding protein","volume":"6","author":"Braunschweig","year":"2011","journal-title":"PLoS ONE"},{"key":"B40","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/ki.2012.463","article-title":"Endogenous and exogenous pentraxin-3 limits postischemic acute and chronic kidney injury","volume":"83","author":"Lech","year":"2013","journal-title":"Kidney Int"},{"key":"B41","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.cell.2015.01.004","article-title":"PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer","volume":"160","author":"Bonavita","year":"2015","journal-title":"Cell"},{"key":"B42","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1084\/jem.20141268","article-title":"An acidic microenvironment sets the humoral pattern recognition molecule PTX3 in a tissue repair mode","volume":"212","author":"Doni","year":"2015","journal-title":"J Exp Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10875-007-9126-7","article-title":"Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3","volume":"28","author":"Mantovani","year":"2008","journal-title":"J Clin Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1161\/01.CIR.0000145167.30987.2E","article-title":"Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction","volume":"110","author":"Latini","year":"2004","journal-title":"Circulation"},{"key":"B45","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1093\/eurjhf\/hfs092","article-title":"Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials","volume":"14","author":"Latini","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"B46","doi-asserted-by":"publisher","first-page":"421429","DOI":"10.1155\/2014\/421429","article-title":"Pentraxin 3 as a prognostic biomarker in patients with systemic inflammation or infection","volume":"2014","author":"Liu","year":"2014","journal-title":"Mediators Inflamm"},{"key":"B47","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/ijc.29822","article-title":"Prognostic and diagnostic potential of local and circulating levels of pentraxin 3 in lung cancer patients","volume":"138","author":"Infante","year":"2016","journal-title":"Int J Cancer"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jinf.2017.10.016","article-title":"Pentraxin-3 as a marker of sepsis severity and predictor of mortality outcomes: a systematic review and meta-analysis","volume":"76","author":"Lee","year":"2018","journal-title":"J Infect"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.micinf.2004.09.004","article-title":"IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection","volume":"7","author":"Azzurri","year":"2005","journal-title":"Microbes Infect"},{"key":"B50","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jinf.2009.04.004","article-title":"Long pentraxin PTX3 is associated with mortality and disease severity in severe Leptospirosis","volume":"58","author":"Wagenaar","year":"2009","journal-title":"J Infect"},{"key":"B51","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/SHK.0b013e31817fd543","article-title":"Ptx3 and C-reactive protein in severe meningococcal disease","volume":"31","author":"Sprong","year":"2009","journal-title":"Shock"},{"key":"B52","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jinf.2009.11.010","article-title":"PTX3 predicts severe disease in febrile patients at the emergency department","volume":"60","author":"de Kruif","year":"2010","journal-title":"J Infect"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e17653","DOI":"10.1371\/journal.pone.0017653","article-title":"High plasma level of long pentraxin 3 (PTX3) is associated with fatal disease in bacteremic patients: a prospective cohort study","volume":"6","author":"Huttunen","year":"2011","journal-title":"PLoS ONE"},{"key":"B54","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1515\/cclm-2012-0459","article-title":"Plasma long pentraxin 3 (PTX3) concentration is a novel marker of disease activity in patients with community-acquired pneumonia","volume":"51","author":"Kao","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"B55","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.hrtlng.2012.11.005","article-title":"Pentraxin 3 in the assessment of ventilator-associated pneumonia: an early marker of severity","volume":"42","author":"Lin","year":"2013","journal-title":"Heart Lung."},{"key":"B56","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/resp.12038","article-title":"Pentraxin-3: a novel biomarker for discriminating parapneumonic from other exudative effusions","volume":"18","author":"Ozsu","year":"2013","journal-title":"Respirology"},{"key":"B57","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1186\/s13054-014-0562-5","article-title":"Alveolar pentraxin 3 as an early marker of microbiologically confirmed pneumonia: a threshold-finding prospective observational study","volume":"18","author":"Mauri","year":"2014","journal-title":"Crit Care"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.2147\/copd.S123528","article-title":"Investigating the role of pentraxin 3 as a biomarker for bacterial infection in subjects with COPD","volume":"12","author":"Thulborn","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"B59","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/jmv.20397","article-title":"Elevated plasma levels of the long pentraxin, pentraxin 3, in severe dengue virus infections","volume":"76","author":"Mairuhu","year":"2005","journal-title":"J Med Virol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/ppul.23199","article-title":"Pentraxin 3 as a clinical marker in children with lower respiratory tract infection","volume":"51","author":"Kim","year":"2016","journal-title":"Pediatr Pulmonol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1097\/MPH.0b013e318180bc1d","article-title":"PTX3 as a potential novel tool for the diagnosis and monitoring of pulmonary fungal infections in immuno-compromised pediatric patients","volume":"30","author":"Biagi","year":"2008","journal-title":"J Pediatr Hematol Oncol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.healun.2017.04.007","article-title":"Pentraxin 3 levels in bronchoalveolar lavage fluid of lung transplant recipients with invasive aspergillosis","volume":"36","author":"Kabbani","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cmi.2018.06.015","article-title":"Pentraxin 3 in bronchoalveolar lavage fluid and plasma in non-neutropenic patients with pulmonary aspergillosis","author":"Li","year":"2018","journal-title":"Clin Microbiol Infect."},{"key":"B64","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1097\/00003246-200107000-00017","article-title":"Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients","volume":"29","author":"Muller","year":"2001","journal-title":"Crit Care Med"},{"key":"B65","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00134-010-1752-5","article-title":"Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality","volume":"36","author":"Mauri","year":"2010","journal-title":"Intensive Care Med"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e73119","DOI":"10.1371\/journal.pone.0073119","article-title":"Pentraxin-3 serum levels are associated with disease severity and mortality in patients with systemic inflammatory response syndrome","volume":"8","author":"Bastrup-Birk","year":"2013","journal-title":"PLoS ONE"},{"key":"B67","doi-asserted-by":"publisher","first-page":"e53661","DOI":"10.1371\/journal.pone.0053661","article-title":"Pentraxin 3 (PTX3) is associated with severe sepsis and fatal disease in emergency room patients with suspected infection: a prospective cohort study","volume":"8","author":"Uusitalo-Seppala","year":"2013","journal-title":"PLoS ONE"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3109\/14767058.2014.947574","article-title":"Pentraxin 3 concentrations of the mothers with preterm premature rupture of membranes and their neonates, and early neonatal outcome","volume":"28","author":"Akin","year":"2015","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B69","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13054-016-1210-z","article-title":"Pentraxin-3 as a marker of disease severity and risk of death in patients with necrotizing soft tissue infections: a nationwide, prospective, observational study","volume":"20","author":"Hansen","year":"2016","journal-title":"Crit Care"},{"key":"B70","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1186\/s12879-017-2606-3","article-title":"Diagnostic value of Pentraxin-3 in patients with sepsis and septic shock in accordance with latest sepsis-3 definitions","volume":"17","author":"Hamed","year":"2017","journal-title":"BMC Infect Dis"},{"key":"B71","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/eci.12704","article-title":"Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial","volume":"47","author":"Caironi","year":"2017","journal-title":"Eur J Clin Invest"},{"key":"B72","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.amjms.2017.01.003","article-title":"Pentraxin 3, a Predicator for 28-Day Mortality in Patients With Septic Shock","volume":"353","author":"Jie","year":"2017","journal-title":"Am J Med Sci"},{"key":"B73","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3349\/ymj.2017.58.2.370","article-title":"Long Pentraxin 3 as a predictive marker of mortality in severe septic patients who received successful early goal-directed therapy","volume":"58","author":"Kim","year":"2017","journal-title":"Yonsei Med J"},{"key":"B74","doi-asserted-by":"publisher","first-page":"999","DOI":"10.7754\/Clin.Lab.2018.180116","article-title":"Pentraxin-3 Predicts Short- and mid-term mortality in patients with sepsis and septic shock during intensive care treatment","volume":"64","author":"Hamed","year":"2018","journal-title":"Clin Lab"},{"key":"B75","doi-asserted-by":"publisher","first-page":"5125","DOI":"10.18632\/oncotarget.23701","article-title":"Pentraxin-3, procalcitonin and lactate as prognostic markers in patients with sepsis and septic shock","volume":"9","author":"Hu","year":"2018","journal-title":"Oncotarget"},{"key":"B76","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jmii.2015.12.006","article-title":"Serum pentraxin-3 and tumor necrosis factor-like weak inducer of apoptosis (TWEAK) predict severity of infections in acute decompensated cirrhotic patients","volume":"50","author":"Fan","year":"2017","journal-title":"J Microbiol Immunol Infect"},{"key":"B77","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/shk.0000000000000756","article-title":"Infectious complications and immune\/inflammatory response in cardiogenic shock patients: a prospective observational study","volume":"47","author":"Parenica","year":"2017","journal-title":"Shock"},{"key":"B78","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1097\/CCM.0b013e3181809aaf","article-title":"Pentraxin 3 in acute respiratory distress syndrome: an early marker of severity","volume":"36","author":"Mauri","year":"2008","journal-title":"Crit Care Med"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1097\/01.Ccm.0000226413.54364.36","article-title":"Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis","volume":"34","author":"Uzzan","year":"2006","journal-title":"Crit Care Med."},{"key":"B80","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1097\/ccm.0b013e318165babb","article-title":"Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations","volume":"36","author":"Becker","year":"2008","journal-title":"Crit Care Med"},{"key":"B81","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/s0140-6736(09)61879-1","article-title":"Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial","volume":"375","author":"Bouadma","year":"2010","journal-title":"Lancet"},{"key":"B82","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1056\/NEJMoa031544","article-title":"Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia","volume":"350","author":"Gibot","year":"2004","journal-title":"N Engl J Med"},{"key":"B83","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1056\/NEJMoa1211161","article-title":"Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation","volume":"370","author":"Cunha","year":"2014","journal-title":"N Engl J Med"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1093\/cid\/civ679","article-title":"PTX3-based genetic testing for risk of aspergillosis after lung transplant","volume":"61","author":"Cunha","year":"2015","journal-title":"Clin Infect Dis"},{"key":"B85","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1093\/cid\/civ386","article-title":"PTX3 polymorphisms and invasive mold infections after solid organ transplant","volume":"61","author":"Wojtowicz","year":"2015","journal-title":"Clin Infect Dis"},{"key":"B86","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1182\/blood-2016-10-743294","article-title":"Validation of single nucleotide polymorphisms in invasive aspergillosis following hematopoietic cell transplantation","volume":"129","author":"Fisher","year":"2017","journal-title":"Blood"},{"key":"B87","doi-asserted-by":"publisher","first-page":"e527","DOI":"10.3324\/haematol.2018.195453","article-title":"Pentraxin-3 polymorphisms and invasive mold infections in acute leukemia patients with intensive chemotherapy","volume":"103","author":"Brunel","year":"2018","journal-title":"Haematologica"},{"key":"B88","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/cid\/cix749","article-title":"Pentraxin 3 gene polymorphisms and pulmonary aspergillosis in chronic obstructive pulmonary disease patients","volume":"66","author":"He","year":"2018","journal-title":"Clin Infect Dis"},{"key":"B89","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/sj.gene.6364410","article-title":"DC-SIGN (CD209), Pentraxin 3 and Vitamin D receptor gene variants associate with pulmonary tubercolosis risk in West-Africans","volume":"8","author":"Olesen","year":"2007","journal-title":"Genes Immun"},{"key":"B90","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/gene.2010.41","article-title":"PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients","volume":"11","author":"Chiarini","year":"2010","journal-title":"Genes Immun"},{"key":"B91","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"J Am Med Assoc"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1056\/NEJMoa1305727","article-title":"Albumin replacement in patients with severe sepsis or septic shock","volume":"370","author":"Caironi","year":"2014","journal-title":"N Engl J Med"},{"key":"B93","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1515\/CCLM.2009.110","article-title":"Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations","volume":"47","author":"Yamasaki","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.placenta.2012.09.009","article-title":"PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR","volume":"33","author":"Cozzi","year":"2012","journal-title":"Placenta"},{"key":"B95","doi-asserted-by":"publisher","first-page":"e53030","DOI":"10.1371\/journal.pone.0053030","article-title":"Influence of pentraxin 3 (PTX3) genetic variants on myocardial infarction risk and PTX3 plasma levels","volume":"7","author":"Barbati","year":"2012","journal-title":"PLoS ONE"},{"key":"B96","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1161\/01.ATV.0000252126.48375.d5","article-title":"Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris","volume":"27","author":"Inoue","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"889","DOI":"10.2215\/CJN.00870207","article-title":"Plasma Pentraxin 3 in chronic kidney disease patients: association with renal function, protein-energy wasting, cardiovascular disease and mortality","volume":"2","author":"Tong","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.tcm.2010.03.005","article-title":"The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases","volume":"20","author":"Norata","year":"2010","journal-title":"Trends Cardiovasc Med"},{"key":"B99","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S1473-3099(15)70112-X","article-title":"Sepsis: a roadmap for future research","volume":"15","author":"Cohen","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"B100","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"43","author":"Rhodes","year":"2017","journal-title":"Int Care Med"},{"key":"B101","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0140-6736(18)30696-2","article-title":"Sepsis and septic shock","volume":"392","author":"Cecconi","year":"2018","journal-title":"Lancet."},{"key":"B102","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4137\/BMI.S29519","article-title":"Biomarkers for Sepsis: What Is and What Might Be?","volume":"10","author":"Biron","year":"2015","journal-title":"Biomark Insights."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00794\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T00:39:22Z","timestamp":1555029562000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00794\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,12]]},"references-count":102,"alternative-id":["10.3389\/fimmu.2019.00794"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00794","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,12]]},"article-number":"794"}}